Remarkably, one in three individuals achieved a 25% reduction in body weight, equating to a loss of 58 pounds Semaglutide (Wegovy): Wegovy users have experienced significant weight loss as well, with adults averaging a 15% reduction in body weight and a 16.1% decrease in BMI among children aged 12 and older Clinical trial comparisons: SURMOUNT-1 (Zepbound): Participants using the highest dose of Zepbound (15 mg) experienced an average weight loss of 21% after 72 weeks SURMOUNT-2 (Zepbound): In adults with type 2 diabetes, the same high dose led to a 12% weight loss after 72 weeks Wegovy trials: Comparable trials for Wegovy have shown an average weight loss of 15% from the starting weight in adults who are overweight or have obesity Cost considerations: The price of these medications is a factor to consider
doi: 10.1038/s41598-017-15567-3 16 ChauhanM.OsbronC
Animal studies have demonstrated that GLP-1 receptor activation in the brain promotes neurogenesis, which is the birth of new neurons
If we continue treating plantar fasciitis as an inflammatory diagnosis, we miss the real pathology
Side effects are rare but can include nausea, vomiting, increased agitation, weight loss, and restlessness
